Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:363595.
doi: 10.1100/2012/363595. Epub 2012 Jun 4.

Long-term prospective study of the influence of estrone levels on events in postmenopausal women with or at high risk for coronary artery disease

Antonio de Padua Mansur  1 , Tereza Cristina B F Silva, Julio Yoshio Takada, Solange Desirée Avakian, Célia Maria C Strunz, Luiz Antonio Machado César, José Mendes Aldrighi, José Antonio F Ramires
Affiliations

Long-term prospective study of the influence of estrone levels on events in postmenopausal women with or at high risk for coronary artery disease

Antonio de Padua Mansur et al. ScientificWorldJournal. 2012.

Abstract

Background: The link between endogenous estrogen, coronary artery disease (CAD), and death in postmenopausal women is uncertain. We analyzed the association between death and blood levels of estrone in postmenopausal women with known coronary artery disease (CAD) or with a high-risk factor score for CAD.

Methods: 251 postmenopausal women age 50-90 years not on estrogen therapy. Fasting blood for estrone and heart disease risk factors were collected at baseline. Women were grouped according to their estrone levels (<15 and ≥15 pg/mL). Fatal events were recorded after 5.8 ± 1.4 years of followup.

Results: The Kaplan-Meier survival curve showed a significant trend (P = 0.039) of greater all-cause mortality in women with low estrone levels (<15 pg/mL). Cox multivariate regression analysis model adjusted for body mass index, diabetes, dyslipidemia, family history, and estrone showed estrone (OR = 0.45; P = 0.038) as the only independent variable for all-cause mortality. Multivariate regression model adjusted for age, body mass index, hypertension, diabetes, dyslipidemia, family history, and estrone showed that only age (OR = 1.06; P = 0.017) was an independent predictor of all-cause mortality.

Conclusions: Postmenopausal women with known CAD or with a high-risk factor score for CAD and low estrone levels (<15 pg/mL) had increased all-cause mortality.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histogram of estrone plasma levels.
Figure 2
Figure 2
Kaplan-Meier curve for all causes of deaths according to estrone levels (<15 pg/mL versus ≥15 pg/mL).
See this image and copyright information in PMC

References

    1. Xing D, Nozell S, Chen YF, Hage F, Oparil S. Estrogen and mechanisms of vascular protection. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29(3):289–295. - PMC - PubMed
    1. Nilsson S, Mäkelä S, Treuter E, et al. Mechanisms of estrogen action. Physiological Reviews. 2001;81(4):1535–1565. - PubMed
    1. Murphy E, Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovascular Research. 2007;75(3):478–486. - PubMed
    1. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Journal of the American Medical Association. 1998;280(7):605–613. - PubMed
    1. Group for the Women's Health Initiative Investigators Writing. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Journal of the American Medical Association. 2002;288:321–333. - PubMed

Publication types